Lucie Muchová, G S Kiran Kumar Reddy, Grant S Wells, Hui Zhao, Hendrik J Vreman, Ronald J Wong, David K Stevenson
Introduction: Metalloporphyrins, competitive heme oxygenase (HO) inhibitors, may potentially be used as drugs for preventing neonatal hyperbilirubinemia. Metalloporphyrins that specifically target the inducible HO-1 without inhibiting the constitutive HO-2 are the most ideal. Zinc protoporphyrin (ZnPP) has the most promise. We have derived a plant-based ZnPP (ZnPP-Plant) and evaluated its inhibitory potency and selectivity for the HO-1 isozyme.
Methods: Eleven-µM ZnPP-Plant or technical grade ZnPP (ZnPP-TG) were added to reaction vials containing heme, NADPH, and adult mouse spleen, brain, and liver sonicates. Gas chromatography was used to measure total in vitro HO activity in sonicates. Percent inhibition of control HO activity was then compared.
Results: At a 11-µM concentration, ZnPP-Plant and ZnPP-TG inhibited HO activity in the liver (69.7 ± 9.3% and 74.2 ± 10.3%, respectively); spleen (65.8 ± 17.9% and 46.8 ± 8.7%, respectively); and brain (54.1 ± 13.3%, and 38.1 ± 13.9%, respectively).
Conclusion: ZnPP-Plant has equal inhibitory potency as ZnPP-TG, and thus has potential use for treating neonatal hyperbilirubinemia.
{"title":"Inhibitory Potency of a Plant-Based Zinc Protoporphyrin on Heme Oxygenase Activity.","authors":"Lucie Muchová, G S Kiran Kumar Reddy, Grant S Wells, Hui Zhao, Hendrik J Vreman, Ronald J Wong, David K Stevenson","doi":"10.1159/000549566","DOIUrl":"10.1159/000549566","url":null,"abstract":"<p><strong>Introduction: </strong>Metalloporphyrins, competitive heme oxygenase (HO) inhibitors, may potentially be used as drugs for preventing neonatal hyperbilirubinemia. Metalloporphyrins that specifically target the inducible HO-1 without inhibiting the constitutive HO-2 are the most ideal. Zinc protoporphyrin (ZnPP) has the most promise. We have derived a plant-based ZnPP (ZnPP-Plant) and evaluated its inhibitory potency and selectivity for the HO-1 isozyme.</p><p><strong>Methods: </strong>Eleven-µM ZnPP-Plant or technical grade ZnPP (ZnPP-TG) were added to reaction vials containing heme, NADPH, and adult mouse spleen, brain, and liver sonicates. Gas chromatography was used to measure total in vitro HO activity in sonicates. Percent inhibition of control HO activity was then compared.</p><p><strong>Results: </strong>At a 11-µM concentration, ZnPP-Plant and ZnPP-TG inhibited HO activity in the liver (69.7 ± 9.3% and 74.2 ± 10.3%, respectively); spleen (65.8 ± 17.9% and 46.8 ± 8.7%, respectively); and brain (54.1 ± 13.3%, and 38.1 ± 13.9%, respectively).</p><p><strong>Conclusion: </strong>ZnPP-Plant has equal inhibitory potency as ZnPP-TG, and thus has potential use for treating neonatal hyperbilirubinemia.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kristina Shcherbatiuk, Clelia Magagnoli, Francesco Susca, Daniele Caratozzolo, Michelle Fiander, Roger Franklin Soll, Matteo Bruschettini, Olga Romantsik
Introduction: Peripheral intravenous catheterization is commonly required in sick neonates but remains challenging due to small vessels, leading to multiple attempts and complications. This review evaluated the benefits and harms of device-assisted techniques versus standard technique.
Methods: We searched MEDLINE, Embase, CENTRAL, Cochrane Reviews, WHO ICTRP, and ClinicalTrials.gov (October 2024) for randomized controlled trials (RCTs). Data collection and analysis followed Cochrane methodology.
Results: We included 12 RCTs (1,251 neonates). Devices were used for placement in 5 studies (417 neonates) and tip confirmation in 6 studies (740 neonates). One study used ultrasound for both PICC placement and tip confirmation (94 neonates). Devices may increase first-attempt success compared to standard technique: risk ratio (RR): 1.18, 95% confidence interval (CI): 1.04-1.33 for placement and RR: 1.20, 95% CI: 1.10-1.30 for tip confirmation. Six studies (528 neonates) reported a shorter time to successful catheterization. Devices likely reduce hematoma (RR: 0.32, 95% CI: 0.13-0.75), bleeding (MD: -0.68, 95% CI: -0.83 to -0.53), and phlebitis (RR: 0.19, 95% CI: 0.06-0.58). Evidence was of very low certainty for thrombosis for placement (RR: 0.33, 95% CI: 0.01-7.99) and tip confirmation (RR: 0.25, 95% CI: 0.05-1.16), catheter-related bloodstream infection (RR: 1.25, 95% CI: 0.34-4.58), and arrhythmia (RR: 0.09, 95% CI: 0.01-0.70).
Conclusion: Device-assisted catheterization may improve first-attempt success and reduce procedure time in neonates. Evidence on safety is limited. Due to variability in study methodologies and outcome reporting, high-quality RCTs with standardized outcome measures are needed.
外周静脉导管置入术通常需要在患病的新生儿,但仍然具有挑战性,由于小血管,导致多次尝试和并发症。本综述评估了器械辅助技术与标准技术的利弊。方法:检索MEDLINE、Embase、CENTRAL、Cochrane Reviews、WHO ICTRP和ClinicalTrials.gov(2024年10月),检索随机对照试验(RCT)。数据收集和分析采用Cochrane方法。结果:我们纳入12项随机对照试验(1251名新生儿)。5项研究(417名新生儿)使用器械放置,6项研究(740名新生儿)使用器械尖端确认。一项研究使用超声同时放置PICC和尖端确认(94名新生儿)。与标准技术相比,器械可能会增加首次尝试的成功率:放置的RR为1.18,95% CI为1.04至1.33,针尖确认的RR为1.20,95% CI为1.10至1.30。6项研究(528名新生儿)报告了导管置入术成功的时间较短。器械可能减少血肿(RR = 0.32, 95% CI = 0.13 ~ 0.75)、出血(MD = -0.68, 95% CI = -0.83 ~ -0.53)和静脉炎(RR = 0.19, 95% CI = 0.06 ~ 0.58)。置管时血栓形成(RR 0.33, 95% CI 0.01 ~ 7.99)和导管头确认(RR 0.25, 95% CI 0.05 ~ 1.16)、导管相关血流感染(RR 1.25, 95% CI 0.34 ~ 4.58)和心律失常(RR 0.09, 95% CI 0.01 ~ 0.70)的证据确定性非常低。结论:器械辅助置管可提高新生儿首次尝试成功率,缩短手术时间。安全性方面的证据有限。由于研究方法和结果报告的可变性,需要具有标准化结果测量的高质量随机对照试验。
{"title":"Devices for Neonatal Peripheral Catheterization and Tip Confirmation: A Systematic Review and Meta-Analysis.","authors":"Kristina Shcherbatiuk, Clelia Magagnoli, Francesco Susca, Daniele Caratozzolo, Michelle Fiander, Roger Franklin Soll, Matteo Bruschettini, Olga Romantsik","doi":"10.1159/000549323","DOIUrl":"10.1159/000549323","url":null,"abstract":"<p><strong>Introduction: </strong>Peripheral intravenous catheterization is commonly required in sick neonates but remains challenging due to small vessels, leading to multiple attempts and complications. This review evaluated the benefits and harms of device-assisted techniques versus standard technique.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, CENTRAL, Cochrane Reviews, WHO ICTRP, and ClinicalTrials.gov (October 2024) for randomized controlled trials (RCTs). Data collection and analysis followed Cochrane methodology.</p><p><strong>Results: </strong>We included 12 RCTs (1,251 neonates). Devices were used for placement in 5 studies (417 neonates) and tip confirmation in 6 studies (740 neonates). One study used ultrasound for both PICC placement and tip confirmation (94 neonates). Devices may increase first-attempt success compared to standard technique: risk ratio (RR): 1.18, 95% confidence interval (CI): 1.04-1.33 for placement and RR: 1.20, 95% CI: 1.10-1.30 for tip confirmation. Six studies (528 neonates) reported a shorter time to successful catheterization. Devices likely reduce hematoma (RR: 0.32, 95% CI: 0.13-0.75), bleeding (MD: -0.68, 95% CI: -0.83 to -0.53), and phlebitis (RR: 0.19, 95% CI: 0.06-0.58). Evidence was of very low certainty for thrombosis for placement (RR: 0.33, 95% CI: 0.01-7.99) and tip confirmation (RR: 0.25, 95% CI: 0.05-1.16), catheter-related bloodstream infection (RR: 1.25, 95% CI: 0.34-4.58), and arrhythmia (RR: 0.09, 95% CI: 0.01-0.70).</p><p><strong>Conclusion: </strong>Device-assisted catheterization may improve first-attempt success and reduce procedure time in neonates. Evidence on safety is limited. Due to variability in study methodologies and outcome reporting, high-quality RCTs with standardized outcome measures are needed.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-17"},"PeriodicalIF":3.0,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12700586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ariel A Salas, Christoph Binder, Cornelia Wiechers, Melanie Gsöellpointner, Nadja Haiden, Christoph Fusch, Niels Rochow
Introduction: There is a need to establish realistic, rather than idealistic, postnatal growth targets. We aimed to characterize body composition outcomes of preterm infants growing along recently defined individualized growth trajectories.
Methods: In this cohort study, infants born <33 weeks of gestation in the United States, Canada, Germany, and Austria between 2012-2022 were included if they had body composition measurements at term-equivalent age. Growth trajectories for each infant were generated retrospectively based on weight data collected at birth and at term-equivalent age. This allowed for the calculation of the difference between actual and target weight at term-equivalent age or discharge and stratification of infants into three growth trajectories: 1) 100g or further below target, 2) within target (±99g), and 3) 100g or more above target.
Results: A total of 1052 infants were included. The median gestational age and birthweight were 28 weeks and 1060g, respectively. A linear correlation between the actual versus target weight difference and fat-free mass (FFM) z-scores was found (r = 0.34, p < 0.0001). Among infants whose weights remained within the target range (30%), the mean FFM z-score was -1.6 [SD: 1.2] and the mean body fat percentage was 15 [SD: 5.9]. In addition to lower mean FFM z-scores, infants whose weight fell below the target range had greater declines in weight, length, and head circumference z-scores.
Conclusions: Weight trajectories below a recently defined target is linked to lower FFM. Further research is needed to determine whether prospectively targeting these individualized growth trajectories improves FFM outcomes.
{"title":"Association between Growth Trajectories and Body Composition Outcomes in Very Preterm Infants: A Cohort Study.","authors":"Ariel A Salas, Christoph Binder, Cornelia Wiechers, Melanie Gsöellpointner, Nadja Haiden, Christoph Fusch, Niels Rochow","doi":"10.1159/000547967","DOIUrl":"https://doi.org/10.1159/000547967","url":null,"abstract":"<p><strong>Introduction: </strong>There is a need to establish realistic, rather than idealistic, postnatal growth targets. We aimed to characterize body composition outcomes of preterm infants growing along recently defined individualized growth trajectories.</p><p><strong>Methods: </strong>In this cohort study, infants born <33 weeks of gestation in the United States, Canada, Germany, and Austria between 2012-2022 were included if they had body composition measurements at term-equivalent age. Growth trajectories for each infant were generated retrospectively based on weight data collected at birth and at term-equivalent age. This allowed for the calculation of the difference between actual and target weight at term-equivalent age or discharge and stratification of infants into three growth trajectories: 1) 100g or further below target, 2) within target (±99g), and 3) 100g or more above target.</p><p><strong>Results: </strong>A total of 1052 infants were included. The median gestational age and birthweight were 28 weeks and 1060g, respectively. A linear correlation between the actual versus target weight difference and fat-free mass (FFM) z-scores was found (r = 0.34, p < 0.0001). Among infants whose weights remained within the target range (30%), the mean FFM z-score was -1.6 [SD: 1.2] and the mean body fat percentage was 15 [SD: 5.9]. In addition to lower mean FFM z-scores, infants whose weight fell below the target range had greater declines in weight, length, and head circumference z-scores.</p><p><strong>Conclusions: </strong>Weight trajectories below a recently defined target is linked to lower FFM. Further research is needed to determine whether prospectively targeting these individualized growth trajectories improves FFM outcomes.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-15"},"PeriodicalIF":3.0,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144877677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Intrauterine herpes simplex virus (HSV) infection is uncommon and challenging to diagnose, requiring detection of HSV in skin lesions within 48 h post-birth.
Case presentation: A preterm female infant presented with the typical triad of blisters, microcephaly, and chorioretinitis, but the initial diagnostic approach was elusive due to negative results for TORCH pathogens from vesicles/serum. Referred at 7 months for developmental delay and epilepsy, her brain imaging showed calcification and cortical dysplasia. Polymerase chain reaction (PCR) of her preserved dried umbilical cord detected HSV-2 DNA, diagnosing intrauterine HSV infection. HSV-2 was later found in relapsed blisters at 8 months but not in cerebrospinal fluid or brain tissue. A literature review identified 104 congenital/intrauterine HSV cases; 28.8% presented the typical triad, and 50% were diagnosed using specimens collected 48 h post-birth.
Conclusion: This case marks the first retrospective diagnosis of intrauterine HSV infection via PCR on preserved umbilical cord, underscoring its diagnostic value.
{"title":"Diagnostic Utility of Preserved Dried Umbilical Cord Polymerase Chain Reaction in Intrauterine Herpes Simplex Virus Infection: A Case Report and Literature Review.","authors":"Yasumasa Tsuda, Takeshi Matsushige, Hirofumi Inoue, Madoka Hoshide, Hiroki Hamano, Keiko Hasegawa, Masako Moriuchi, Hiroyuki Moriuchi, Shunji Hasegawa","doi":"10.1159/000540506","DOIUrl":"10.1159/000540506","url":null,"abstract":"<p><strong>Introduction: </strong>Intrauterine herpes simplex virus (HSV) infection is uncommon and challenging to diagnose, requiring detection of HSV in skin lesions within 48 h post-birth.</p><p><strong>Case presentation: </strong>A preterm female infant presented with the typical triad of blisters, microcephaly, and chorioretinitis, but the initial diagnostic approach was elusive due to negative results for TORCH pathogens from vesicles/serum. Referred at 7 months for developmental delay and epilepsy, her brain imaging showed calcification and cortical dysplasia. Polymerase chain reaction (PCR) of her preserved dried umbilical cord detected HSV-2 DNA, diagnosing intrauterine HSV infection. HSV-2 was later found in relapsed blisters at 8 months but not in cerebrospinal fluid or brain tissue. A literature review identified 104 congenital/intrauterine HSV cases; 28.8% presented the typical triad, and 50% were diagnosed using specimens collected 48 h post-birth.</p><p><strong>Conclusion: </strong>This case marks the first retrospective diagnosis of intrauterine HSV infection via PCR on preserved umbilical cord, underscoring its diagnostic value.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"27-31"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-06-21DOI: 10.1159/000538905
Vito D'Andrea, Giorgia Prontera, Francesco Cota, Alessandro Perri, Rosellina Russo, Giovanni Barone, Giovanni Vento
Introduction: The umbilical venous catheter is a vital access device in neonatal intensive care units for preterm and critically ill infants. Correct positioning is crucial, as malpositioning can lead to severe complications. According to international guidelines, the position of the umbilical venous catheter tip must be assessed in real time; traditionally, the catheter is visualized with a thoracoabdominal X-ray, but one of the most effective and safest methods is therefore real-time ultrasound.
Methods: This study compares real-time ultrasound and traditional X-ray methods for assessing umbilical venous catheter tip location in 461 cases. The rate of tip malposition was analyzed retrospectively. The secondary aim was to assess indwelling time of umbilical venous catheters and reasons of removal.
Results: Real-time ultrasound tip location, found to be more reliable and efficient, demonstrated a significantly lower incidence of primary malpositioning compared to X-ray assessments (9.6 vs. 75.9%). The study also highlighted the association of real-time ultrasound with reduced catheter manipulation, fewer radiographs, and higher indwelling times of umbilical venous catheter. The multiple logistic regression showed a high probability of the central safe position of the umbilical venous catheter tip using real-time ultrasound tip location (odds ratio 29.5, 95% confidence interval: 17.4-49.4).
Conclusion: The findings support the adoption of real-time ultrasound in clinical settings to enhance umbilical venous catheter placement accuracy and minimize associated risks. A minimal training investment is needed to attain the proficiency to visualize the umbilical venous catheters, offering a substantial advantage in terms of both cost-effectiveness for the procedure and enhanced patient safety.
导言:脐静脉导管是新生儿重症监护室中早产儿和重症婴儿的重要通路设备。正确定位至关重要,因为定位不当会导致严重的并发症。根据国际指南,必须实时评估脐静脉导管尖端的位置;传统上,导管通过胸腹部 X 光片观察,但最有效、最安全的方法之一是实时超声:本研究比较了 461 个病例中评估脐静脉导管尖端位置的实时超声和传统 X 光方法。回顾性分析了导管尖端错位率。次要目的是评估脐静脉导管的留置时间和移除原因:与 X 光评估相比,实时超声尖端定位更可靠、更高效,原发性错位的发生率明显较低(9.6% 对 75.9%)。该研究还强调了实时超声与导管操作减少、X 光检查次数减少和脐静脉导管留置时间延长的关系。多元逻辑回归结果显示,使用实时超声检查导管尖端位置,脐静脉导管尖端中心安全位置的概率很高(几率比29.5,95%置信区间:17.4-49.4):研究结果支持在临床环境中采用实时超声来提高脐静脉导管置管的准确性,并将相关风险降至最低。只需投入极少的培训费用即可熟练掌握脐静脉导管的可视化操作,在手术的成本效益和提高患者安全性方面都具有很大的优势。
{"title":"Real-Time Ultrasound Tip Location Reduces Malposition and Radiation Exposure during Umbilical Venous Catheter Placement in Neonates: A Retrospective, Observational Study.","authors":"Vito D'Andrea, Giorgia Prontera, Francesco Cota, Alessandro Perri, Rosellina Russo, Giovanni Barone, Giovanni Vento","doi":"10.1159/000538905","DOIUrl":"10.1159/000538905","url":null,"abstract":"<p><strong>Introduction: </strong>The umbilical venous catheter is a vital access device in neonatal intensive care units for preterm and critically ill infants. Correct positioning is crucial, as malpositioning can lead to severe complications. According to international guidelines, the position of the umbilical venous catheter tip must be assessed in real time; traditionally, the catheter is visualized with a thoracoabdominal X-ray, but one of the most effective and safest methods is therefore real-time ultrasound.</p><p><strong>Methods: </strong>This study compares real-time ultrasound and traditional X-ray methods for assessing umbilical venous catheter tip location in 461 cases. The rate of tip malposition was analyzed retrospectively. The secondary aim was to assess indwelling time of umbilical venous catheters and reasons of removal.</p><p><strong>Results: </strong>Real-time ultrasound tip location, found to be more reliable and efficient, demonstrated a significantly lower incidence of primary malpositioning compared to X-ray assessments (9.6 vs. 75.9%). The study also highlighted the association of real-time ultrasound with reduced catheter manipulation, fewer radiographs, and higher indwelling times of umbilical venous catheter. The multiple logistic regression showed a high probability of the central safe position of the umbilical venous catheter tip using real-time ultrasound tip location (odds ratio 29.5, 95% confidence interval: 17.4-49.4).</p><p><strong>Conclusion: </strong>The findings support the adoption of real-time ultrasound in clinical settings to enhance umbilical venous catheter placement accuracy and minimize associated risks. A minimal training investment is needed to attain the proficiency to visualize the umbilical venous catheters, offering a substantial advantage in terms of both cost-effectiveness for the procedure and enhanced patient safety.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"32-37"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-11-11DOI: 10.1159/000542538
Christian A Maiwald, Christian F Poets, Axel R Franz
{"title":"Response to Härtel et al.: \"Less Invasive Surfactant Administration for Preterm Infants - State of the Art\".","authors":"Christian A Maiwald, Christian F Poets, Axel R Franz","doi":"10.1159/000542538","DOIUrl":"10.1159/000542538","url":null,"abstract":"","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"251-252"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-06-21DOI: 10.1159/000539175
Miguel Alsina-Casanova, Mathias Lühr-Hansen, Victoria Aldecoa-Bilbao, Ruth Del Rio, Pierre Maton, Kosmas Sarafidis, Pamela Zafra-Rodriguez, Zachary Andrew Vesoulis, Emmanuele Mastretta, Ilia Bresesti, Marta Gomez-Chiari, Mónica Rebollo, Jamil Khamis, Angelos Baltatzidis, Isabel Benavente-Fernandez, Joshua Shimony, Giovanni Morana, Massimo Agosti, Nuria Carreras, Adriana Cuaresma, Ambre Gau, Athanasia Anastasiou, Simón Pedro Lubian-López, Dimitrios Alexopoulos, Paola Sciortino, Francesca Dessimone, Markus Harboe Olsen, Thais Agut, Gorm Greisen
Introduction: The SafeBoosC-III trial investigated the effect of cerebral oximetry-guided treatment in the first 72 h after birth on mortality and severe brain injury diagnosed by cranial ultrasound in extremely preterm infants (EPIs). This ancillary study evaluated the effect of cerebral oximetry on global brain injury as assessed by magnetic resonance imaging (MRI) at term equivalent age (TEA).
Methods: MRI scans were obtained between 36 and 44.9 weeks PMA. The Kidokoro score was independently evaluated by two blinded assessors. The intervention effect was assessed using the nonparametric Wilcoxon rank sum test for median difference and 95% Hodges-Lehmann (HL) confidence intervals (CIs). The intraclass correlation coefficient (ICC) was used to assess the agreement between the assessors.
Results: A total of 210 patients from 8 centers were included, of whom 121 underwent MRI at TEA (75.6% of alive patients): 57 in the cerebral oximetry group and 64 in the usual care group. There was an excellent correlation between the assessors for the Kidokoro score (ICC agreement: 0.93, 95% CI: 0.91-0.95). The results showed no significant differences between the cerebral oximetry group (median 2, interquartile range [IQR]: 1-4) and the usual care group (median 3, IQR: 1-4; median difference -1 to 0, 95% HLCI: -1 to 0; p value 0.1196).
Conclusions: In EPI, the use of cerebral oximetry-guided treatment did not lead to significant alterations in brain injury, as determined by MRI at TEA. The strong correlation between the assessors highlights the potential of the Kidokoro score in multicenter trials.
{"title":"Effect of Cerebral Oximetry-Guided Treatment on Brain Injury in Preterm Infants as Assessed by Magnetic Resonance Imaging at Term Equivalent Age: An Ancillary SafeBoosC-III Study.","authors":"Miguel Alsina-Casanova, Mathias Lühr-Hansen, Victoria Aldecoa-Bilbao, Ruth Del Rio, Pierre Maton, Kosmas Sarafidis, Pamela Zafra-Rodriguez, Zachary Andrew Vesoulis, Emmanuele Mastretta, Ilia Bresesti, Marta Gomez-Chiari, Mónica Rebollo, Jamil Khamis, Angelos Baltatzidis, Isabel Benavente-Fernandez, Joshua Shimony, Giovanni Morana, Massimo Agosti, Nuria Carreras, Adriana Cuaresma, Ambre Gau, Athanasia Anastasiou, Simón Pedro Lubian-López, Dimitrios Alexopoulos, Paola Sciortino, Francesca Dessimone, Markus Harboe Olsen, Thais Agut, Gorm Greisen","doi":"10.1159/000539175","DOIUrl":"10.1159/000539175","url":null,"abstract":"<p><strong>Introduction: </strong>The SafeBoosC-III trial investigated the effect of cerebral oximetry-guided treatment in the first 72 h after birth on mortality and severe brain injury diagnosed by cranial ultrasound in extremely preterm infants (EPIs). This ancillary study evaluated the effect of cerebral oximetry on global brain injury as assessed by magnetic resonance imaging (MRI) at term equivalent age (TEA).</p><p><strong>Methods: </strong>MRI scans were obtained between 36 and 44.9 weeks PMA. The Kidokoro score was independently evaluated by two blinded assessors. The intervention effect was assessed using the nonparametric Wilcoxon rank sum test for median difference and 95% Hodges-Lehmann (HL) confidence intervals (CIs). The intraclass correlation coefficient (ICC) was used to assess the agreement between the assessors.</p><p><strong>Results: </strong>A total of 210 patients from 8 centers were included, of whom 121 underwent MRI at TEA (75.6% of alive patients): 57 in the cerebral oximetry group and 64 in the usual care group. There was an excellent correlation between the assessors for the Kidokoro score (ICC agreement: 0.93, 95% CI: 0.91-0.95). The results showed no significant differences between the cerebral oximetry group (median 2, interquartile range [IQR]: 1-4) and the usual care group (median 3, IQR: 1-4; median difference -1 to 0, 95% HLCI: -1 to 0; p value 0.1196).</p><p><strong>Conclusions: </strong>In EPI, the use of cerebral oximetry-guided treatment did not lead to significant alterations in brain injury, as determined by MRI at TEA. The strong correlation between the assessors highlights the potential of the Kidokoro score in multicenter trials.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"38-45"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-11-26DOI: 10.1159/000542154
Maha Azhar, Rahima Yasin, Sawera Hanif, Sharib Afzal Bughio, Jai K Das, Zulfiqar A Bhutta
<p><strong>Introduction: </strong>Preterm and low birth weight (LBW) infants are at an increased risk of morbidity and mortality compared with their term counterparts, with more than 20 million LBW infants born each year, the majority in lower middle-income countries (LMICs). Given the increased vulnerability and higher nutritional needs of these infants, optimizing feeding strategies may play a crucial role in improving their health outcomes.</p><p><strong>Methods: </strong>We updated evidence of Every Newborn Series published in The Lancet 2014 by identifying relevant systematic reviews, extracting low-income country (LIC) and LMIC data, and conducting revised meta-analysis for these contexts.</p><p><strong>Results: </strong>We found 15 reviews; the evidence showed that early initiation of enteral feeding reduced neonatal mortality overall, but not in LIC/LMIC settings. Breastfeeding promotion interventions increased the prevalence of early initiation of breastfeeding and exclusive breastfeeding at 3 and 6 months of age in LMIC settings. There was an increased risk of neonatal mortality with formula milk in LIC/LMIC settings. Despite contributing to greater weight gain, there was a higher risk of necrotizing enterocolitis with formula milk overall. Breast milk fortification and nutrient-enriched formula improved growth outcomes. Iron and vitamin A supplementation reduced anemia and mortality rates (LMIC), respectively. The evidence also suggested that benefits of various different micronutrient supplementation interventions such as zinc, calcium/phosphorous, and vitamin D, outweigh the risks since our review demonstrates little to no adverse effects deriving from their supplementation, particularly for a breastfed preterm and/or LBW infant.</p><p><strong>Conclusion: </strong>Early adequate nutritional support of preterm or LBW infant is paramount to averse adverse health outcomes, contribute to normal growth, resistance to infection, and optimal development. Breast milk feeding and micronutrient supplementation are crucial to reduce diarrhea incidence and mortality respectively while feed fortification or nutrient-enriched formula, when breast milk is not available, to enhance better growth especially in LMICs where there is higher population of growth restriction and stunting. This review also highlights need for randomized trials in LMICs at large scale to further strengthen the evidence.</p><p><strong>Introduction: </strong>Preterm and low birth weight (LBW) infants are at an increased risk of morbidity and mortality compared with their term counterparts, with more than 20 million LBW infants born each year, the majority in lower middle-income countries (LMICs). Given the increased vulnerability and higher nutritional needs of these infants, optimizing feeding strategies may play a crucial role in improving their health outcomes.</p><p><strong>Methods: </strong>We updated evidence of Every Newborn Series published in The Lancet 2014 by ident
导言:与足月儿相比,早产儿和低出生体重儿的发病率和死亡率风险更高,每年有 2000 多万低出生体重儿出生,其中大部分在中低收入国家(LMICs)。鉴于这些婴儿的脆弱性增加且营养需求更高,优化喂养策略可能对改善他们的健康状况起到至关重要的作用:我们更新了《柳叶刀》杂志 2014 年发表的 "每个新生儿系列 "的证据,确定了相关的系统综述,提取了低收入国家(LIC)和中低收入国家(LMIC)的数据,并针对这些情况进行了修订后的荟萃分析:结果:我们找到了 15 篇综述;证据显示,早期开始肠内喂养总体上降低了新生儿死亡率,但在低收入国家/低收入中等收入国家环境中并没有降低。在低收入和中等收入国家环境中,母乳喂养推广干预措施提高了早期开始母乳喂养和 3 个月及 6 个月纯母乳喂养的普及率。在低收入国家/低收入和中等收入国家,使用配方奶的新生儿死亡风险增加。尽管配方奶有助于增加体重,但总体而言,使用配方奶发生坏死性小肠结肠炎的风险更高。母乳强化和营养丰富的配方奶可改善生长结果。铁和维生素 A 补充剂分别降低了贫血率和死亡率(低收入与中等收入国家)。证据还表明,锌、钙/磷和维生素 D 等各种微量营养素补充干预措施的益处大于风险,因为我们的综述显示,补充这些营养素几乎不会产生不良影响,尤其是对母乳喂养的早产儿和/或低体重儿:结论:早产儿或低体重儿早期获得充足的营养支持对避免不良健康后果、促进正常生长、抵抗感染和最佳发育至关重要。母乳喂养和微量营养素补充分别对降低腹泻发病率和死亡率至关重要,而在没有母乳的情况下,强化饲料或营养丰富的配方奶粉则能促进婴儿更好地成长,尤其是在生长受限和发育迟缓人群较多的低收入和中等收入国家。本综述还强调需要在低收入和中等收入国家进行大规模随机试验,以进一步加强证据。
{"title":"Nutritional Management of Low Birth Weight and Preterm Infants in Low- and Low Middle-Income Countries.","authors":"Maha Azhar, Rahima Yasin, Sawera Hanif, Sharib Afzal Bughio, Jai K Das, Zulfiqar A Bhutta","doi":"10.1159/000542154","DOIUrl":"10.1159/000542154","url":null,"abstract":"<p><strong>Introduction: </strong>Preterm and low birth weight (LBW) infants are at an increased risk of morbidity and mortality compared with their term counterparts, with more than 20 million LBW infants born each year, the majority in lower middle-income countries (LMICs). Given the increased vulnerability and higher nutritional needs of these infants, optimizing feeding strategies may play a crucial role in improving their health outcomes.</p><p><strong>Methods: </strong>We updated evidence of Every Newborn Series published in The Lancet 2014 by identifying relevant systematic reviews, extracting low-income country (LIC) and LMIC data, and conducting revised meta-analysis for these contexts.</p><p><strong>Results: </strong>We found 15 reviews; the evidence showed that early initiation of enteral feeding reduced neonatal mortality overall, but not in LIC/LMIC settings. Breastfeeding promotion interventions increased the prevalence of early initiation of breastfeeding and exclusive breastfeeding at 3 and 6 months of age in LMIC settings. There was an increased risk of neonatal mortality with formula milk in LIC/LMIC settings. Despite contributing to greater weight gain, there was a higher risk of necrotizing enterocolitis with formula milk overall. Breast milk fortification and nutrient-enriched formula improved growth outcomes. Iron and vitamin A supplementation reduced anemia and mortality rates (LMIC), respectively. The evidence also suggested that benefits of various different micronutrient supplementation interventions such as zinc, calcium/phosphorous, and vitamin D, outweigh the risks since our review demonstrates little to no adverse effects deriving from their supplementation, particularly for a breastfed preterm and/or LBW infant.</p><p><strong>Conclusion: </strong>Early adequate nutritional support of preterm or LBW infant is paramount to averse adverse health outcomes, contribute to normal growth, resistance to infection, and optimal development. Breast milk feeding and micronutrient supplementation are crucial to reduce diarrhea incidence and mortality respectively while feed fortification or nutrient-enriched formula, when breast milk is not available, to enhance better growth especially in LMICs where there is higher population of growth restriction and stunting. This review also highlights need for randomized trials in LMICs at large scale to further strengthen the evidence.</p><p><strong>Introduction: </strong>Preterm and low birth weight (LBW) infants are at an increased risk of morbidity and mortality compared with their term counterparts, with more than 20 million LBW infants born each year, the majority in lower middle-income countries (LMICs). Given the increased vulnerability and higher nutritional needs of these infants, optimizing feeding strategies may play a crucial role in improving their health outcomes.</p><p><strong>Methods: </strong>We updated evidence of Every Newborn Series published in The Lancet 2014 by ident","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"209-223"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-11-19DOI: 10.1159/000542540
Jan Hulscher, Willemijn Irvine, Andrea Conforti, Antonio Di Cesare, Martina Ichino, Rony Sfeir, Omid Madadi Sanjani, Joanna Strohm, Maria Hukkinen, Laura Moschino, Lorenzo Norsa, Alena Kokešová, Roel Bakx, Elisabeth Kooi, Sylvia Obermann-Borst, Elena Palleri, Marijn Vermeulen, Marie Spruce, Udo Rolle, Marc Miserez, Irene de Haro Jorge, Claudia Keyzer-Dekker, Francesco Fascetti Leon, Iris den Uijl, Simon Eaton, Carmen Mesas Burgos
Necrotizing enterocolitis (NEC) is a severe intestinal condition primarily affecting preterm neonates. It has a high mortality rate, particularly in infants with a birthweight of below 1,500 g or for those requiring surgical intervention. The European Reference Network for Inherited and Congenital Anomalies (ERNICA) has developed a clinical practice guideline to aid clinical decision-making pertaining to the surgical treatment and management of NEC in preterm neonates. This guideline was developed in accordance with the Guidelines 2.0 checklist and GRADE methodology. A multidisciplinary group of Europe's top experts collaborated with patient representatives to develop this guideline. After selecting critical points in care for which recommendations are required, a systematic review of the literature and critical appraisal of the evidence was performed. The Evidence to Decision framework was used as a guide to structure the consensus meetings and draft the recommendations. The panel developed seven recommendations and three good practice statements on the following topics: indications for surgery, peritoneal drainage, surgical technique, management of extensive NEC, enteral feeding, and neurodevelopmental outcomes in premature neonates with NEC. The certainty of evidence was graded as (very) low for most recommendations. However, the panel weighed up the benefits and harms in light of all relevant arguments and expert opinion. This guideline provides recommendations on caring for premature neonates with NEC. These recommendations can assist clinicians in their care decisions and can inform families on treatment options and relevant considerations. This guideline will be revised every 5 years to ensure it remains up to date.
{"title":"European Reference Network for Inherited and Congenital Anomalies Evidence-Based Guideline on Surgical Aspects of Necrotizing Enterocolitis in Premature Neonates.","authors":"Jan Hulscher, Willemijn Irvine, Andrea Conforti, Antonio Di Cesare, Martina Ichino, Rony Sfeir, Omid Madadi Sanjani, Joanna Strohm, Maria Hukkinen, Laura Moschino, Lorenzo Norsa, Alena Kokešová, Roel Bakx, Elisabeth Kooi, Sylvia Obermann-Borst, Elena Palleri, Marijn Vermeulen, Marie Spruce, Udo Rolle, Marc Miserez, Irene de Haro Jorge, Claudia Keyzer-Dekker, Francesco Fascetti Leon, Iris den Uijl, Simon Eaton, Carmen Mesas Burgos","doi":"10.1159/000542540","DOIUrl":"10.1159/000542540","url":null,"abstract":"<p><p>Necrotizing enterocolitis (NEC) is a severe intestinal condition primarily affecting preterm neonates. It has a high mortality rate, particularly in infants with a birthweight of below 1,500 g or for those requiring surgical intervention. The European Reference Network for Inherited and Congenital Anomalies (ERNICA) has developed a clinical practice guideline to aid clinical decision-making pertaining to the surgical treatment and management of NEC in preterm neonates. This guideline was developed in accordance with the Guidelines 2.0 checklist and GRADE methodology. A multidisciplinary group of Europe's top experts collaborated with patient representatives to develop this guideline. After selecting critical points in care for which recommendations are required, a systematic review of the literature and critical appraisal of the evidence was performed. The Evidence to Decision framework was used as a guide to structure the consensus meetings and draft the recommendations. The panel developed seven recommendations and three good practice statements on the following topics: indications for surgery, peritoneal drainage, surgical technique, management of extensive NEC, enteral feeding, and neurodevelopmental outcomes in premature neonates with NEC. The certainty of evidence was graded as (very) low for most recommendations. However, the panel weighed up the benefits and harms in light of all relevant arguments and expert opinion. This guideline provides recommendations on caring for premature neonates with NEC. These recommendations can assist clinicians in their care decisions and can inform families on treatment options and relevant considerations. This guideline will be revised every 5 years to ensure it remains up to date.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"376-384"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-03-06DOI: 10.1159/000545106
Sreeja Kothapally, Chandra Rath, Bhanu B Gowda, Jay Sharma, Sanjay K Patole, Shripada Rao
Introduction: Ideal early postnatal weight loss (PWL) and its association with mortality and morbidity in preterm infants are not well known. This review explored the association between early PWL and outcomes in very premature infants (<32 weeks).
Methods: This is a systematic review and meta-analyses of the observational studies. PubMed, Medline, EMBASE, Cochrane Library, EMCARE, and MedNar databases were searched in April 2024. Outcomes of interest were mortality and morbidities such as intraventricular haemorrhage (IVH), chronic lung disease (CLD), patent ductus arteriosus, necrotising enterocolitis (NEC), retinopathy of prematurity, and long-term neurodevelopmental outcomes. Data were pooled separately for adjusted and unadjusted odds ratios (ORs) using random-effects model. Separate analyses were conducted for case-control and cohort studies. Data were pooled separately for the excess weight loss (EWL) group (>15% from birth weight) and inadequate weight loss (IWL) group (<5% from birth weight).
Results: Eighteen studies (25,158 infants) were included. Pooling of adjusted ORs in EWL group from cohort studies found significant association with mortality (OR 1.39 confidence interval [CI; 1.10-1.75]), severe IVH (OR 1.37 CI [1.18-1.59]), NEC (OR 2.05 CI [1.05-4.03]), and "Mortality or IVH" (OR 1.40 CI [1.10-1.78]). Pooling adjusted ORs from case-control studies showed a significant association between EWL and CLD and between IWL and mortality or CLD. Certainty of evidence was "Low" or "Very-low."
Conclusion: EWL or IWL in very preterm infants may be associated with higher odds of mortality and morbidity. However, cofactors of severity of associated disease, insufficient nutrition, and treatments could not be assessed.
{"title":"Early Postnatal Weight Loss and Its Association with Outcomes in Very Preterm Neonates: A Systematic Review and Meta-Analysis.","authors":"Sreeja Kothapally, Chandra Rath, Bhanu B Gowda, Jay Sharma, Sanjay K Patole, Shripada Rao","doi":"10.1159/000545106","DOIUrl":"10.1159/000545106","url":null,"abstract":"<p><strong>Introduction: </strong>Ideal early postnatal weight loss (PWL) and its association with mortality and morbidity in preterm infants are not well known. This review explored the association between early PWL and outcomes in very premature infants (<32 weeks).</p><p><strong>Methods: </strong>This is a systematic review and meta-analyses of the observational studies. PubMed, Medline, EMBASE, Cochrane Library, EMCARE, and MedNar databases were searched in April 2024. Outcomes of interest were mortality and morbidities such as intraventricular haemorrhage (IVH), chronic lung disease (CLD), patent ductus arteriosus, necrotising enterocolitis (NEC), retinopathy of prematurity, and long-term neurodevelopmental outcomes. Data were pooled separately for adjusted and unadjusted odds ratios (ORs) using random-effects model. Separate analyses were conducted for case-control and cohort studies. Data were pooled separately for the excess weight loss (EWL) group (>15% from birth weight) and inadequate weight loss (IWL) group (<5% from birth weight).</p><p><strong>Results: </strong>Eighteen studies (25,158 infants) were included. Pooling of adjusted ORs in EWL group from cohort studies found significant association with mortality (OR 1.39 confidence interval [CI; 1.10-1.75]), severe IVH (OR 1.37 CI [1.18-1.59]), NEC (OR 2.05 CI [1.05-4.03]), and \"Mortality or IVH\" (OR 1.40 CI [1.10-1.78]). Pooling adjusted ORs from case-control studies showed a significant association between EWL and CLD and between IWL and mortality or CLD. Certainty of evidence was \"Low\" or \"Very-low.\"</p><p><strong>Conclusion: </strong>EWL or IWL in very preterm infants may be associated with higher odds of mortality and morbidity. However, cofactors of severity of associated disease, insufficient nutrition, and treatments could not be assessed.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"477-494"},"PeriodicalIF":3.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12060839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143575067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}